High Dose Chemotherapy with Autologous Stem Cell Rescue in Adults with Malignant Primary Brain Tumors

[1]  W. Mason,et al.  Survival following intensive chemotherapy with bone marrow reconstitution for children with recurrent intracranial ependymoma A report of the Children's Cancer Group , 1998, Journal of Neuro-Oncology.

[2]  J. Finlay,et al.  High dose chemotherapy with autologous stem cell rescue for patients with medulloblastoma , 1996, Journal of Neuro-Oncology.

[3]  H. Friedman,et al.  Response of recurrent medulloblastoma to low-dose oral etoposide. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  S. Piantadosi,et al.  The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: Phase I trial , 1995, Journal of Neuro-Oncology.

[5]  J. Kurtzberg,et al.  Cyclophosphamide in combination with sargramostim for treatment of recurrent medulloblastoma. , 1995, Medical and Pediatric Oncology.

[6]  W. Hall,et al.  Stereotactic radiosurgery for recurrent malignant gliomas. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  S. Piantadosi,et al.  Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas , 1995, The Lancet.

[8]  P. Biron,et al.  High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor‐prognosis germ cell tumors and metastatic trophoblastic disease in adults , 1995, Cancer.

[9]  P. Wen,et al.  Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. , 1995, Neurosurgery.

[10]  P. Gutin,et al.  Brachytherapy and hyperthermia for malignant astrocytomas. , 1994, Seminars in oncology.

[11]  R. Motzer,et al.  Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors. , 1993, Journal of the National Cancer Institute.

[12]  D. V. Von Hoff,et al.  Durable complete remission in a patient with refractory mediastinal non-seminomatous germ cell tumor after tandem high-dose chemotherapy and autologous bone marrow transplantation. , 1993, Bone marrow transplantation.

[13]  H. Fine,et al.  High-dose chemotherapy with autologous bone marrow transplantation in the treatment of high grade astrocytomas in adults: therapeutic rationale and clinical experience. , 1992, Bone marrow transplantation.

[14]  G. Vassal,et al.  High-dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: a phase II study. , 1992, Bone marrow transplantation.

[15]  S. Donaldson,et al.  Medulloblastoma: freedom from relapse longer than 8 years--a therapeutic cure? , 1991, Journal of neurosurgery.

[16]  N. Greig,et al.  Increasing annual incidence of primary malignant brain tumors in the elderly. , 1990, Journal of the National Cancer Institute.

[17]  E Wiltshaw,et al.  Carboplatin dosage: prospective evaluation of a simple formula based on renal function. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  J. Thompson,et al.  Prolongation of survival for high-grade malignant gliomas with adjuvant high-dose BCNU and autologous bone marrow transplantation. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  S. Wolff,et al.  High-dose carmustine with autologous bone marrow transplantation for the adjuvant treatment of high-grade gliomas of the central nervous system. , 1987, Cancer treatment reports.

[20]  J. Fay,et al.  Intensive 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  F. Schabel,et al.  Increasing the therapeutic response rates to anticancer drugs by applying the basic principles of pharmacology , 1984, Pharmacology & therapeutics.

[22]  W. Markesbery,et al.  Reoperation for glioblastoma. , 1981, Journal of neurosurgery.

[23]  L. Parker,et al.  High-dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme. , 1981, Journal of neurosurgery.

[24]  D Riddoch,et al.  Neoplasms of the central nervous system. , 1977, The Practitioner.

[25]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[26]  R. Livingston,et al.  High dose BCNU with autologous bone marrow rescue in the treatment of recurrent malignant gliomas , 2004, Journal of Neuro-Oncology.

[27]  E. Bouffet,et al.  Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma? , 2004, Journal of Neuro-Oncology.

[28]  M. Rosenblum,et al.  High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  S. Rodenhuis,et al.  Pilot study of a high-dose carboplatin-based salvage strategy for relapsing or refractory germ cell cancer. , 1995, Cancer investigation.

[30]  K. Lindsley.  Surveillance scanning of children with medulloblastoma. , 1994, The New England journal of medicine.

[31]  M. Prados,et al.  Thermoradiotherapy of recurrent malignant brain tumors. , 1992, International journal of radiation oncology, biology, physics.

[32]  M. Malkin.  Interstitial irradiation of malignant gliomas. , 1992, Revue neurologique.